Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125380941 | 12538094 | 1 | I | 20160320 | 20160630 | 20160707 | 20160707 | EXP | FR-SA-2016SA122669 | AVENTIS | 86.00 | YR | E | F | Y | 0.00000 | 20160707 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125380941 | 12538094 | 1 | PS | APIDRA | INSULIN GLULISINE | 1 | Subcutaneous | Y | UNK | 21629 | 4 | IU | BID | ||||||
| 125380941 | 12538094 | 2 | C | LASILIX | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 125380941 | 12538094 | 3 | C | TRIATEC | RAMIPRIL | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 125380941 | 12538094 | 4 | C | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | 0 | 200 | MG | TABLET | QD | |||||||
| 125380941 | 12538094 | 5 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 0 | 18 | IU | QD | ||||||||
| 125380941 | 12538094 | 6 | C | CARDENSIEL | BISOPROLOL FUMARATE | 1 | Oral | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||||
| 125380941 | 12538094 | 7 | C | DEROXAT | PAROXETINE HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 125380941 | 12538094 | 8 | C | COUMADINE | WARFARIN SODIUM | 1 | Oral | 0 | 2 | MG | TABLET | QD | |||||||
| 125380941 | 12538094 | 9 | C | EFFERALGAN | ACETAMINOPHEN | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 125380941 | 12538094 | 10 | C | SMECTA | MONTMORILLONITE | 1 | Oral | 0 | 1 | DF | TID | ||||||||
| 125380941 | 12538094 | 11 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 0 | 1 | DF | GASTRO-RESISTANT TABLET | QD | |||||||
| 125380941 | 12538094 | 12 | C | CALCIDOSE VITAMINE D | CALCIUMCHOLECALCIFEROL | 1 | Oral | 0 | 2 | DF | ORAL POWDER | QD | |||||||
| 125380941 | 12538094 | 13 | C | KALEORID | POTASSIUM CHLORIDE | 1 | Oral | 0 | 600 | MG | PROLONGED-RELEASE TABLET | QD | |||||||
| 125380941 | 12538094 | 14 | C | PROCTOLOG | TRIMEBUTINE | 1 | Rectal | 0 | 10 | DF | QD | ||||||||
| 125380941 | 12538094 | 15 | C | LOPERAMIDE | LOPERAMIDE | 1 | Oral | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125380941 | 12538094 | 1 | Type 1 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125380941 | 12538094 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125380941 | 12538094 | Fall | |
| 125380941 | 12538094 | Hypoglycaemia | |
| 125380941 | 12538094 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125380941 | 12538094 | 1 | 20160323 | 0 | ||
| 125380941 | 12538094 | 11 | 20160323 | 0 |